drugset / Trial / NCT01980069

A Double-blind, Randomized, Parallel Design Study to Compare the Effectiveness of Sugammadex Versus Neostigmine in Improving Surgical Condition in Subjects Undergoing Laryngeal Microsurgery

NCT01980069

Completed 72 enrolled Yonsei University
RandomizedParallel-groupDouble-blindTreatment

Summary

Investigators hypothesized that the surgical condition will be improved with the use of sugammadex in patients undergoing laryngeal microsurgery. Investigators will compare the effect of sugammadex and neostigmine on the surgical condition during laryngeal microsurgery.

Timeline

Start
2013-11
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 50 ug/kg Intravenous
Comparator Sugammadex Other / unclassified 2 mg/kg Intravenous
Comparator Sugammadex Other / unclassified 4 mg/kg Intravenous
Comparator Sugammadex Other / unclassified 8 mg/kg Intravenous
Background Glycopyrrolate Small molecule 10 ug/kg

Indications

No indication recorded.